ArticleArchives of microbiology2026
Determination and characterization of nucleotidases associated to polysomes of Trypanosoma Cruzi.
Article in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Trypanosoma cruzi causes American trypanosomiasis or Chagas Disease, a neglected tropical disease with cardiac, digestive and neurological involvement that can be fatal, and for which there are few effective antiparasitic drugs. EF3 is an elongation factor with ATPase activity present in fungi, which are not present in mammalian; it is essential for protein synthesis in these organisms, this molecule is also present in some protist parasites, so the objective of this work was the determination and characterization of nucleotidases associated with polysomes of T. cruzi. The nucleotidase activity of T. cruzi polysomes was studied and compared with that found in human ribosomes. Epimastigotes of T. cruzi were processed by subcellular fractionation techniques, obtaining the fractions: kinetoplasts (K), polysomal (P) and soluble (S100). The ability to hydrolyze ATP in each fraction was determined measuring the inorganic phosphate (Pi) released. The total ATPase activity was distributed between K (11.6%) and P (9.4%), while S100 did not present activity. The highest specific activity was found in K (116 ± 1 nmol/Pi/mg protein), followed by P (83 ± 3 nmol/Pi/mg protein). The preferential substrate of polysomal nucleotidases was ATP, followed by GTP. Ouabain and vanadate inhibited polysomal ATPase activity by 39% and 68%, respectively. Sequence comparison analysis of EF3 and T. cruzi nucleotidases and molecular modeling were performed, demonstrating that nucleotidase activity does not correspond to a possible EF3 analogue in T. cruzi. Differences with human ribosomal ATPase could be exploited for chemotherapeutic control of the parasite.
Indexed as
Identifiers
41524782What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.